Somatic-type delusional disorder: a case report and comments. 2011

Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003702 Delusions A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates. Delusion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013001 Somatoform Disorders Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V) Briquet Syndrome,Pain Disorder,Somatization Disorder,Medically Unexplained Syndrome,Medically Unexplained Syndromes,Disorder, Somatoform,Somatization Disorders,Somatoform Disorder,Syndrome, Briquet,Syndrome, Medically Unexplained,Unexplained Syndrome, Medically
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D016312 Treatment Refusal Patient or client refusal of or resistance to medical, psychological, or psychiatric treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.) Avoidance of Health Care,Avoidance of Healthcare,Avoided Health Care,Avoided Healthcare,Health Care Avoidance,Healthcare Avoidance,Patient Refusal of Treatment,Refusal of Treatment,Anesthesia Refusal,Patient Elopement,Anesthesia Refusals,Elopement, Patient,Refusal, Anesthesia,Refusals, Anesthesia,Treatment Refusals

Related Publications

Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
March 2010, African journal of psychiatry,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
March 2008, Psychiatria Danubina,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
July 2004, Human psychopharmacology,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
May 1999, International clinical psychopharmacology,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
March 1988, Journal of the American Academy of Child and Adolescent Psychiatry,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
October 2019, Dermatology online journal,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
June 2013, The Journal of nervous and mental disease,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
September 2008, Journal of psychopharmacology (Oxford, England),
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
October 2012, Acta neuropsychiatrica,
Anna Kepska, and Tomasz Hawro, and Maria Krupinska-Kun, and Anna Zalewska
March 2024, Cureus,
Copied contents to your clipboard!